Skip to main content

Table 1 Correlation of PLEK2 expression with the clinicopathological features of GBC

From: PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway

 

PLEK2(High)

PLEK2 (Low)

P value

N = 83

%

N = 66

%

 

Sexual

    

0.623

 Male

27

0.181

19

0.128

 

 Female

56

0.376

47

0.315

 

Age (years)

    

0.271

  ≤ 65

39

0.262

37

0.248

 

  > 65

44

0.295

29

0.195

 

Tumor size (cm)

    

0.256

  ≤ 3

35

0.235

34

0.228

 

  > 3

48

0.322

32

0.215

 

T

    

0.010*

 1–2

9

0.060

18

0.121

 

 3–4

74

0.497

48

0.322

 

N

    

0.195

 0

48

0.322

45

0.302

 

 1–2

35

0.235

21

0.141

 

M

    

0.841

 No

82

0.550

64

0.430

 

 Yes

1

0.007

2

0.013

 

TNM stage

    

0.010*

 I-II

9

0.060

18

0.121

 

 III-IV

74

0.497

48

0.322

 

Tumor location

    

0.336

 Body or bottom

73

0.490

62

0.416

 

 Neck or duct

10

0.067

4

0.027

 

Liver metastasis

    

0.014*

 No

44

0.295

48

0.322

 

 Yes

39

0.262

18

0.121

 
  1. *P < 0.05 was considered statistically significant
  2. χ2 test was performed